These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27622513)

  • 1. Is There Any Difference between the In Situ and Systemic IL-10 and IFN-γ Production when Clinical Forms of Cutaneous Sporotrichosis Are Compared?
    Morgado FN; Schubach AO; Pimentel MI; Lyra MR; Vasconcellos ÉC; Valete-Rosalino CM; Conceição-Silva F
    PLoS One; 2016; 11(9):e0162764. PubMed ID: 27622513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1/Th17 response in vitro.
    Verdan FF; Faleiros JC; Ferreira LS; Monnazzi LG; Maia DC; Tansine A; Placeres MC; Carlos IZ; Santos-Junior RR
    Immunobiology; 2012 Aug; 217(8):788-94. PubMed ID: 22656886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of Cytokines and Hydrogen Peroxide to Sporothrix schenckii Exoantigen in Systemic Experimental Infection.
    Maia DC; Gonçalves AC; Ferreira LS; Manente FA; Portuondo DL; Vellosa JC; Polesi MC; Batista-Duharte A; Carlos IZ
    Mycopathologia; 2016 Apr; 181(3-4):207-15. PubMed ID: 26603044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of virulence of different Sporothrix schenckii clinical isolates using experimental murine model.
    Brito MM; Conceição-Silva F; Morgado FN; Raibolt PS; Schubach A; Schubach TP; Schäffer GM; Borba CM
    Med Mycol; 2007 Dec; 45(8):721-9. PubMed ID: 17885952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence.
    Uenotsuchi T; Takeuchi S; Matsuda T; Urabe K; Koga T; Uchi H; Nakahara T; Fukagawa S; Kawasaki M; Kajiwara H; Yoshida S; Moroi Y; Furue M
    Int Immunol; 2006 Dec; 18(12):1637-46. PubMed ID: 17035348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of major components from Sporothrix schenckii cell wall in the caspase-1 activation, nitric oxide and cytokines production during experimental sporotrichosis.
    Gonçalves AC; Maia DC; Ferreira LS; Monnazzi LG; Alegranci P; Placeres MC; Batista-Duharte A; Carlos IZ
    Mycopathologia; 2015 Feb; 179(1-2):21-30. PubMed ID: 25205196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in situ inflammatory profile of lymphocutaneous and fixed forms of human sporotrichosis.
    Morgado FN; Schubach AO; Barros MB; Conceição-Silva F
    Med Mycol; 2011 Aug; 49(6):612-20. PubMed ID: 21254963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Response Induced by an Immunodominant 60 kDa Glycoprotein of the Cell Wall of Sporothrix schenckii in Two Mice Strains with Experimental Sporotrichosis.
    Alba-Fierro CA; Pérez-Torres A; Toriello C; Pulido-Camarillo E; López-Romero E; Romo-Lozano Y; Gutiérrez-Sánchez G; Ruiz-Baca E
    J Immunol Res; 2016; 2016():6525831. PubMed ID: 27051673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporothrix brasiliensis induces a more severe disease associated with sustained Th17 and regulatory T cells responses than Sporothrix schenckii sensu stricto in mice.
    Batista-Duharte A; Téllez-Martínez D; Roberto de Andrade C; Portuondo DL; Jellmayer JA; Polesi MC; Carlos IZ
    Fungal Biol; 2018 Dec; 122(12):1163-1170. PubMed ID: 30449354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taenia taeniaeformis in rat favors protracted skin lesions caused by Sporothrix schenckii infection: Dectin-1 and IL-17 are dispensable for clearance of this fungus.
    Zhang X; Zhang J; Huang H; Xue R; Hu X; Li M; Zhong Y; Yuan L
    PLoS One; 2012; 7(12):e52514. PubMed ID: 23285072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships among genotypes, virulence and clinical forms of Sporothrix schenckii infection.
    Kong X; Xiao T; Lin J; Wang Y; Chen HD
    Clin Microbiol Infect; 2006 Nov; 12(11):1077-81. PubMed ID: 17002606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection.
    Portuondo DL; Batista-Duharte A; Ferreira LS; Martínez DT; Polesi MC; Duarte RA; de Paula E Silva AC; Marcos CM; Almeida AM; Carlos IZ
    Immunobiology; 2016 Feb; 221(2):300-9. PubMed ID: 26547105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin Mast Cells Contribute to
    Jiao Q; Luo Y; Scheffel J; Geng P; Wang Y; Frischbutter S; Li R; Maurer M; Zhao Z
    Front Immunol; 2020; 11():469. PubMed ID: 32265923
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii.
    Ferreira LS; Portuondo DL; Polesi MC; Carlos IZ
    Immunology; 2018 Dec; 155(4):467-476. PubMed ID: 30030839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant murine IL-12 promotes a protective Th1/cellular response in Mongolian gerbils infected with Sporothrix schenckii.
    Flores-García A; Velarde-Félix JS; Garibaldi-Becerra V; Rangel-Villalobos H; Torres-Bugarín O; Zepeda-Carrillo EA; Ruíz-Bernés S; Ochoa-Ramírez LA
    J Chemother; 2015 Feb; 27(2):87-93. PubMed ID: 24548095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of Sporothrix schenckii from the environmental sources of cutaneous sporotrichosis patients in Himachal Pradesh, India: results of a pilot study.
    Mehta KI; Sharma NL; Kanga AK; Mahajan VK; Ranjan N
    Mycoses; 2007 Nov; 50(6):496-501. PubMed ID: 17944713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molluscum-like lesions in a patient with sporotrichosis.
    Schechtman RC; Crignis GS; Pockstaller MP; Azulay-Abulafia L; Quintella LP; Belo M
    An Bras Dermatol; 2011; 86(6):1217-9. PubMed ID: 22281918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory activity of Vismia guianensis (Aubl.) Pers. extracts and antifungal activity against Sporothrix schenckii.
    Oliveira AH; de Oliveira GG; Carnevale Neto F; Portuondo DF; Batista-Duharte A; Carlos IZ
    J Ethnopharmacol; 2017 Jan; 195():266-274. PubMed ID: 27856302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse bone marrow-derived dendritic cells can phagocytize the Sporothrix schenckii, and mature and activate the immune response by secreting interleukin-12 and presenting antigens to T lymphocytes.
    Kusuhara M; Qian H; Li X; Tsuruta D; Tsuchisaka A; Ishii N; Ohata C; Furumura M; Hashimoto T
    J Dermatol; 2014 May; 41(5):386-92. PubMed ID: 24750442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection.
    Romo-Lozano Y; Hernández-Hernández F; Salinas E
    Scand J Immunol; 2012 Jul; 76(1):11-20. PubMed ID: 22486186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.